Nonclinical Biodistribution for Frataxin
Time: 9:00 am
day: Conference Day One
Details:
- Discussing the importance of biodistribution studies to understand AAV vector distribution and target tissue specificity
- Identifying AAV accumulation in non-target tissues to predict and mitigate potential adverse events
- Validating novel techniques to improve biodistribution studies
